Dror Dicker, MD

Rabin Medical Center, Israel

Disclosure(s): AstraZenca: Advisor/Consultant, Honoraria; Beyond Air: Grant/Research Support; Boehringer Ingelheim: Advisor/Consultant, Honoraria; Eli Lilly: Grant/Research Support; Novo Nordisk: Advisor/Consultant, Grant/Research Support, Honoraria

Poster(s):

• 2190 - Characterization of Inhaled Nitric Oxide (iNO) for the treatment of Viral Community Acquired Pneumonia (CAP)
  Saturday, October 22, 2022

  12:15 PM – 1:30 PM US ET